TNF and COVID-19: These targeted therapies are used to treat both inflammatory diseases with more aggressive phenotypes, and severely ill patients with COVID-19, considering the major contribution of TNF and IL-6 to the cytokine-storm syndrome observed in critical patients (13, 14, 25).